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Role of Corticotropin-releasing Factor in 
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The interface between the intestinal lumen and the mucosa is the location where the majority of ingested immunogenic par-
ticles face the scrutiny of the vast gastrointestinal immune system. Upon regular physiological conditions, the intestinal micro-
flora and the epithelial barrier are well prepared to process daily a huge amount of food-derived antigens and non-immuno-
genic particles. Similarly, they are ready to prevent environmental toxins and microbial antigens to penetrate further and inter-
act with the mucosal-associated immune system. These functions promote the development of proper immune responses and 
oral tolerance and prevent disease and inflammation. Brain-gut axis structures participate in the processing and execution of 
response signals to external and internal stimuli. The brain-gut axis integrates local and distant regulatory networks and super-
systems that serve key housekeeping physiological functions including the balanced functioning of the intestinal barrier. 
Disturbance of the brain-gut axis may induce intestinal barrier dysfunction, increasing the risk of uncontrolled immunological 
reactions, which may indeed trigger transient mucosal inflammation and gut disease. There is a large body of evidence indicat-
ing that stress, through the brain-gut axis, may cause intestinal barrier dysfunction, mainly via the systemic and peripheral re-
lease of corticotropin-releasing factor. In this review, we describe the role of stress and corticotropin-releasing factor in the reg-
ulation of gastrointestinal permeability, and discuss the link to both health and pathological conditions.
(J Neurogastroenterol Motil 2015;21:33-50)
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Official abbreviations according to UPHARM guideline were used 
in this review series.
CRF, corticotrophin-releasing factor
CRF1, corticotrophin-releasing factor receptor 1
CRF2, corticotrophin-releasing factor receptor 2
Introduction
The epithelium that lines our digestive tract harbors 100 tril-
lion bacteria1 and mediates our relationship to the world outside. 
Our intestine is constantly exposed to a wide variety of immuno-
genic particles and microorganism-derived antigens. Its surface 
area is large enough to process over 50 tons of food in a lifetime. 
Intestinal and microbial components are strongly linked to each 
other and represent the most important barrier to limit luminal 
antigens from travelling across and reach the mucosal-associated 
immune system. They also play a critical role in training and 
modulating our immune system, helping it to distinguish be-
tween friend and foe.2,3 The absence of constructive engagement 
between microbes and intestinal mucosa may render epithelial 
barrier more permeable, allowing it to be breached. When this 
happens, resident cells become over-activated, and a cascade of 
pro-inflammatory signals is initiated.4,5 Altered intestinal perme-
ability has large implications for human health, being involved in 
the origin and development of many digestive and non-digestive 
diseases. However, up to date, it is not clear whether intestinal 
barrier dysfunction is a primary event, an epiphenomenon or a 
consequence in the pathogenesis of these disorders.
The regulation of intestinal permeability involves terminals 
from ascending and descending pathways from the autonomic 
nervous system and the central nervous system, the hypothalamic 
pituitary-adrenal axis, and the enteric nervous system as well. The 
vast and versatile array of bidirectional and integrative communica-
tions between the brain and the gut allows the brain to respond to 
internal and external signals and, in return, to modify the autonom-
ic and enteric nervous systems to keep intestinal permeability tight.
Physical and psychological stresses represent convincing evi-
dence of the influence of the brain-gut axis on the intestinal bar-
rier function. In fact, stress has been associated with reactivation 
of inflammatory and functional gastrointestinal disorders mainly 
through disruption of the intestinal barrier6 in both human and 
animal models. The stress response is vehiculated via 2 main sys-
tems: the sympatho-adrenomedullary system and the hypo-
thalamic pituitary-adrenal axis. Stress stimulates the parvocellular 
neurons in the paraventricular nucleus of the hypothalamus to se-
crete corticotropin-releasing factor (CRF), and arginine vaso-
pressin. CRF promotes the synthesis and release of adenocortico-
tropic hormone in the anterior pituitary. The adenocorticotropic 
hormone, in turn, activates the adrenal cortex to induce a tempo-
rary rise in blood levels of cortisol and corticosterone7 and also the 
release of catecholamines by the adrenal medulla. It has been be-
lieved for a long time that central secretion of CRF was the main 
and unique mediator of the majority of the endocrine, behavioral 
and gastrointestinal changes induced by stress.8 However, we will 
show that peripheral release of CRF also plays a key role in the 
regulation of gastrointestinal permeability, and discuss the link to 
both health and pathological conditions.
Intestinal Permeability
The intestinal mucosal barrier includes several consecutive 
layers, from the outermost microbiota, through the external mu-
cus, the epithelium, and down to the innermost lamina propria.9 
The epithelial layer is described as a continuous polarized mono-
layer of columnar cells that separates the intestinal lumen from 
the internal milieu. Aside from epithelial cells, a variety of differ-
ent cell types are also intermingled with enterocytes, including 
goblet cells, Paneth cells, enteroendocrine cells, and M cells. 
Within the lamina propria we can find blood and lymph vessels, 
and a plethora of distinct immune cells such as plasma cells, lym-
phocytes, macrophages, eosinophils, mast cells, dendritic cells, 
and a significant number of intrinsic and extrinsic nerve ter-
minals.10 All of these components are exquisitely reactive and 
adaptive and display critical effector and modulatory functions. 
These functions are relevant for the control of inflammation, ab-
sorption and secretion, transport of macromolecules, and meta-
bolic processes.11 Moreover, most of the cellular components 
have been shown to express receptors for CRF.12,13 But the job of 
the intestinal barrier now appears to be far more nuanced and 
complex as it communicates multidirectionally with the immune 
system and the microbes. Communication is developed through 
the release of an extensive array of chemical mediators, namely 
neuropeptides, neurohormones, neurotransmitters, cytokines, 
chemokines, growth factors, and other regulatory molecules.14,15
Enterocytes are tightly bonded to each other sealing the para-
cellular space through the apical junctional complex, composed of 
tight junctions (TJs), adherens junctions, and desmosomes.16 
The transmembrane TJ proteins occludin and claudins form 
complex protein systems, which interact with zonula occludens 
proteins that bind to the actin cytoskeleton. When actin contracts, 
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Figure. Corticotropin-releasing factor actions on gastrointestinal permeability under stress conditions. JAM-A-B-C, junctional adhesion molecule 
A-B-C; SP, substance P; ACh, acetylcholine; MBP, major basic protein; CRF, corticotropin- releasing factor; CRF1, CRF receptor 1; CRF2, CRF 
receptor 2; PAR2, protease activated receptor 2.
it leads to increased permeability to electrolytes and small 
molecules.17 The paracellular space is not fully impermeable to 
molecules and antigens, allowing a controlled amount of small 
particles (less than 400 daltons) to penetrate across to reach the 
lamina propria,9 a phenomenon that plays a key role in the in-
duction of immune tolerance. This passage of molecules also 
takes place through the transcellular pathway via endocytosis or 
exocytosis.18 Disruption of the intestinal barrier leads to uncon-
trolled flux of luminal antigens and possibly microbes across the 
epithelium, which may trigger immune activation and sepsis, and 
also lead to the development of chronic inflammation in the 
gut.6,19,20 Therefore, the tight regulation of intestinal permeability 
emerges as a central mechanism to prevent inflammatory diseases. 
Numerous pathogens and toxins, hormones and neurotrans-
mitters, and gastrointestinal and non-gastrointestinal diseases 
have been associated with an augmented intestinal permeability.21 
Among them, stress hormones and neurotransmitters have been 
consistently shown to modulate ion and water secretion, intestinal 
permeability, mucus secretion, and also intestinal flora.22-25
Stress-induced Intestinal Barrier 
Dysfunction: Role of Corticotropin-
releasing Factor and Related Peptides
Stress represents a threat to the internal homeostasis that ini-
tiates a systemic coordinated response driven by the autonomic, 
endocrine, and immune systems to maintain stability. CRF and 
other members of the CRF signaling family, including urocortin 
(Ucn) 1, Ucn2, and Ucn3, are the best known and most im-
portant neuroendocrine mediators of the stress response.26,27 
Central release of CRF and urocortins mediates autonomic, hor-
monal, and behavioural responses to stress and at the gastro-
intestinal tract, stimulates the enteric nervous system to modulate 
gastrointestinal motility and secretion.28-30 In addition, immune 
cells, regional sensory and sympathetic nerves, enterochromaffin 
cells, and enteric cells release CRF and urocortins within the gas-
trointestinal tract28 to modulate mucosal function and gastro-
intestinal motility.29
Different type of stress, acute or chronic, physical or psycho-
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logical, have been shown to influence properties of the intestinal 
barrier function, including ion and water secretion, intestinal per-
meability, mucus secretion, and also intestinal flora in both hu-
man and animal models.6,31-35 Similarly, both central and periph-
eral administration of exogenous CRF have been shown to mimic 
the effects of acute stress in the gastrointestinal tract inducing 
mucin release,36 and increasing ion and water secretion and in-
testinal permeability.37,38 Figure summarizes the main effects of 
stress on the intestinal barrier and the role of CRF in gastro-
intestinal permeability.
Mucus Production and Release
The intestinal mucosal surface is covered by a layer of mucus 
gel containing antibacterial peptides and digestive enzymes.39,40 
Mucus protects the epithelial lining from adhesion and invasion 
by attacking microorganisms, and other antigens present in the 
intestinal lumen.41 Mucus is produced by goblet cells, which ex-
press the CRF receptor 1 (CRF1).
42 Stress has been shown to in-
crease mucin release in colonic explants from rats submitted to 
immobilization, and to enhance rat mast cell protease II and pros-
taglandin E2 secretion. Intravenous or intracerebral injection of 
CRF in non-stressed rats reproduced stress-associated changes 
whereas administration of the CRF antagonist -helical-CRF9-41 
or the mast cell stabilizer lodoxamide inhibited them.36 In addi-
tion, those changes were abolished in mast-cell deficient mice, 
highlighting the key role of the CRF-mast cell axis in stress- 
mediated mucin release.43 On the contrary, rats submitted to 
chronic stress display mucus depletion and reduced number of 
goblet cells in the distal colon in association with increased bacte-
rial adhesion and penetration into enterocytes,44,45 what could 
represent a step towards intestinal barrier dysfunction.
Ion and Water Secretion
Ion and water secretions also help to prevent the adhesion of 
pathogens and noxious substances to the mucosal surface, and di-
lute and flush out them down the gut to minimize their pene-
tration to the lamina propria. Convergent evidences from studies 
in animal models indicate that both water and ion secretions in-
crease in the intestinal tract in response to acute and chronic 
stress24,46 and in response to peripheral administration of CRF47 
whereas selective CRF1 receptor agonists prevent this response to 
stress.48,49 Increased baseline short-circuit current (Isc), indicative 
of enhanced anion secretion, was found in the jejunum of Wistar- 
Kyoto rats submitted to restraint stress or cold restraint stress 
when compared to non-stressed rats. This increase in Isc was 
mediated by chloride anion secretion because replacement of the 
buffer by chloride free solution normalized Isc values.50 Later, 
Santos et al37,51 reproduced the results using a model of repetitive 
exposure to water avoidance stress (WAS) and found that periph-
eral CRF reproduced stress-induced rat jejunal and colonic epi-
thelial barrier dysfunction via cholinergic and adrenergic nerves, 
and mast cells. More recently, long-term crowding exposure, a 
model of psychosocial stress, has been shown to increase baseline 
Isc in both the jejunum and the colon compared to non-stressed 
animals.52 Interestingly, colonic tissues from stressed rats exhi-
bited a reduced Isc response to the addition of cholinergic ago-
nists and CRF, suggesting an impaired secretory response to in-
coming stressful stimuli. Mitochondrial activity was disturbed 
throughout the intestine, although mitochondrial response to 
CRF was preserved. These changes were associated with an in-
creased expression of CRF1 receptor  in the colon of stressed 
rats and colonic hyperalgesia.53 Several other studies using vari-
ous stress models have reproduced the elevation of Isc in the co-
lon and ileum of rodents and showed the involvement of CRF 
receptors.24,33,45,50,54-56
Both the acute intraperitoneal administration of CRF and 
chronic peripheral administration of CRF, the selective CRF1 re-
ceptor agonist stressin-1 and the selective CRF2 receptor ligand, 
Ucn3, increase the basal rat colonic Isc.33,57 Therefore, a role for 
both CRF receptor subtypes in this alteration is suggested, al-
though the response is not reduced by the selective CRF2 re-
ceptor antagonist antisauvagine.57 Furthermore, elevated baseline 
Isc has been also observed in the jejunum of early-weaned pigs, 
while activation of mast cells and CRF induced elevations in Isc 
in the pig jejunum mounted in Ussing chambers. This elevation 
in Isc was inhibited using mast cell protease inhibitors.58 
Experiments using selective CRF receptor antagonists reveal that 
CRF1 receptor activation mediates barrier dysfunction and hy-
persecretion in the porcine intestine in response to early life 
stress.58
Apart from ex vivo and in vivo studies, convincing evidence 
for a direct effect of CRF peptides on intestinal epithelial secre-
tory response comes from in vitro work showing a consistent in-
crease in Isc induced by CRF in the rat colon.33,37,59 Interestingly, 
maximal Isc increments were obtained with sauvagine, a CRF ag-
onist with high affinity to both CRF receptors, at doses 200-1000 
fold lower than CRF, suggesting a predominant CRF2 receptor 
effect.59 In addition, the effect of peripheral CRF on Isc increase 
in rat colonic tissue implicates mast cells, and nicotinic and mus-
carinic receptors, as established by the pharmacological blockade 
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of specific receptors and the use of mast cell deficient rats.37,57 
Other studies performed in the guinea-pig support the ample dis-
tribution of CRF1 receptor, but not CRF2 receptor  throughout 
the myenteric and submucosal plexuses of the gastrointestinal 
tract.60 However, all CRF and Ucn1, Ucn2, and Ucn3 were able 
to increase the excitability of neurons from the enteric nervous 
system in vitro.61
Experimental studies in humans reveal that acute physical or 
psychological stress modulate the intestinal barrier. More than 20 
years ago, Barclay and Turnberg et al,62,63 using segmental perfu-
sion techniques in the human jejunum, showed that acute stress 
reduced net water absorption or increased secretion, supporting 
the role of the central and the autonomic nervous system in the 
control of intestinal function. In particular, a reduction in water 
absorption coupled with net sodium/chloride secretion was ob-
served in healthy subjects subjected to psychological stress in-
duced by dichotomous listening.62,63 Later, Santos et al64 showed 
that cold pain stress increased jejunal water secretion in healthy 
subjects and in patients with food allergy. These observations 
have been confirmed and extended recently: using the cold press-
or test. The increase in intestinal water secretion during cold pain 
stress was higher in healthy female volunteers with lower back-
ground stress levels, yet blunted in those with elevated back-
ground stress.65 These results suggest that chronic life stress 
could lead to the loss of regulatory mechanisms in healthy in-
dividuals, as previously described in the jejunum of chronic 
stressed rats after neural stimulation.50 CRF1 receptor is ex-
pressed throughout the gastrointestinal tract in healthy subjects, 
and located in the lamina propria, mostly in macrophages, epi-
thelial cells and enteric neurons, with the highest levels in the 
ileum and rectum and the lowest level in the colon.66 CRF2 re-
ceptors are located in the lamina propria and in the epithelial cells 
of the distal/sigmoid biopsy samples in healthy subjects.67 In con-
trast to animal studies, the addition of CRF to human colonic bi-
opsies from healthy individuals mounted in Ussing chambers did 
not show any effect on Isc.68 
Permeability
Numerous studies demonstrate the enhancement of intestinal 
permeability by acute and chronic stressors. In rodents, acute or 
subchronic stressors, including restraint stress, cold restraint 
stress, WAS, mild noise stress, and mixed restraint and acoustic 
stress, increased tissue conductance, and the fluxes of 3H man-
nitol,51 Cr-labeled EDTA, horseradish peroxidase, in the jeju-
num, ileum, and colon.32,50,54,69-72 These results indicate the abil-
ity of stress to modulate paracellular and transcellular transport of 
ions, and small and large macromolecules. Multiple mechanisms 
have been invocated to explain stress-mediated transport abnor-
malities. The list includes acetylcholine release, histamine, gluca-
gon-like peptide-2, myosin light chain kinase, cytokines such as 
interferon-, interleukin (IL)-4 and IL-13, and mast cell activa-
tion, among the most relevant.32,61,71,73-75 Moreover, increased in-
testinal permeability, measured by lactulose, mannitol and sucra-
lose ratios, was found in rats’ small intestine, following acute 
swimming stress.23 This increase was glucocorticoid-mediated 
because adrenalectomy and pharmacologic blockade of gluco-
corticoid receptors inhibited the response, and dexamethasone in-
creased gastrointestinal permeability in control rats.23
Similarly, rats models of chronic stress (maternal depriva-
tion,55,77-79 WAS,45 and crowding stress52) also show increased 
ionic permeability, and macromolecular permeability throughout 
the intestine. The increase was mediated partly by mechanisms 
including, muscarinic and nicotinic pathways, activation and 
number of mast cells and the release of nerve growth factor.79 
Stress-induced enhancement of colonic permeability was mim-
icked by exogenous administration of CRF,33 and abolished by 
pretreatment with the peripheral administration of the non-se-
lective CRF antagonists astressin or -helical CRF9-41.37,55,80 
Likely, the selective CRF1 receptor agonist, cortagine,
48 the se-
lective CRF1 receptor antagonist, SSR-125543,
80 and the se-
lective CRF2 receptor antagonist, antisauvagine-30,
78 reduced 
the response, supporting the participation of both CRF receptors 
in the modulation of colonic permeability.
More recently, studies in several cultured epithelial cell lines, 
including intestinal human HT-29 cells, showed that CRF in-
duced the upregulation of the endotoxin receptor, toll-like re-
ceptor 4 (TLR4), and that pretreatment with the CRF2 receptor 
antagonist, antalarmin, abrogated the response. The concomitant 
presence of CRF and lipopolysaccharide increased permeability 
to horseradish peroxidase and decreased transepithelial resist-
ance. This effect was abolished by the CRF2 receptor antagonist, 
astressin2-B, and was mediated through the upregulation of clau-
din-2. Similarly, the expression of TLR4 and claudin-2 increased 
in the small and large intestine of pregnant mice submitted to 10 
days of WAS, as was enhanced the permeability to horseradish 
peroxidase, and the effect abolished by -helical CRF9-4181 and 
anti-claudin antibodies. Interestingly, rats submitted to WAS for 
10 days, showed higher sensitization to orally-delivered horse-
radish peroxidase, as shown by enhanced intestinal permeability 
upon antigen re-exposure. This effect was prevented by CRF 
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blockade with by -helical CRF9-41.82
Another line of evidence in animal models highlights the rele-
vance of stress-CRF-mast cell axis in the regulation of intestinal 
permeability. Elevation of intestinal permeability, in response to 
restraint stress or intraperitoneal administration of CRF, was re-
duced or abolished after pretreatment with doxantrazole.59 
Similarly, pharmacological inhibition of mast cell activation has 
been shown to inhibit stress-induced increased intestinal perme-
ability in different animal models.37,58,59,83 Stress/CRF-induced 
changes in the rat intestinal permeability were also significantly 
reduced in tissues from mast-cell deficient rats.45,51,59,84 Teitelbaum 
et al57 also found CRF to cause mast cell hyperplasia and abnor-
mal bacterial attachment and/or penetration into the rat mucosa 
except in mast-cell deficient rats. The authors revealed that stim-
ulation of CRF1 receptor induced an elevated secretory state, 
while CRF2 receptor stimulation was associated with perme-
ability dysfunction.57 Although it is clear that mast cell activation 
disrupts intestinal barrier and increases intestinal permeability, 
the ultimate mechanisms remain to be elucidated. In this sense, 
several mast cell mediators have been involved. Tumor necrosis 
factor- (TNF-) has been shown to increase intestinal perme-
ability through nuclear factor-kappa B activation in association 
with nuclear factor-kappa B-dependent downregulation of zona 
occludens protein-1 expression and alteration in junctional local-
ization in Caco-2 cells,85 and through myosin light chain kinase 
phosphorylation.86 More recently, using a porcine ex vivo in-
testinal model, Overman et al87 found that CRF increased in-
testinal paracellular permeability via mast cell dependent release 
of TNF- and proteases. On the other hand, the tryptase re-
leased by mast cells upon activation has been shown to induce TJs 
disassembly through the activation of proteinase-activated re-
ceptor-2 of the epithelial cells.88-90 These receptors can modulate 
enteric neurotransmission, secretion, motility, epithelial perme-
ability, and visceral sensitivity, and are also known to regulate in-
testinal inflammation.91 Anatomical contacts between mast cells 
and enteric nerve fibers have been demonstrated in the human 
gastrointestinal mucosa and inflammation multiplies these 
contacts.92,93 Mast cells communicate, bidirectionally, with both 
the enteric, autonomic and central nervous system through mast 
cell mediators and neuropeptides.94 In fact, human mast cells syn-
thesize and secrete both CRF and Ucn in response to im-
munoglobulin E receptor activation.95 Mast cells also express 
CRF receptors, whose activation leads to the release of cytokines 
and other pro-inflammatory mediators. CRF enhances the trans-
cellular uptake of macromolecules in the human colonic mucosa 
in vitro, via CRF receptor subtypes CRF1 and CRF2 expressed 
on subepithelial mast cells.58 CRF1 and CRF2 receptors have 
been described in human umbilical cord blood-derived mast 
cells, while only CRF1 receptor has been found in the human leu-
kemic mast cell HMC-1 line. CRF stimulation induces the secre-
tion of vascular endothelial growth factor without tryptase, hista-
mine, IL-6, IL-8, or TNF- release through CRF1 receptor.96 
More recently, acute stress- induced bladder vascular perme-
ability and vascular endothelial growth factor release have been 
shown to be dependent on CRF2 receptor.
97
It is important to note here the ability of eosinophils to alter 
intestinal permeability and the mechanisms and mediators in-
volved.98 Barrier function has been shown to be affected by eosi-
nophil-derived major basic protein (MBP) through downregula-
tion of occludin in a mast cell independent fashion.98 The neuro-
peptide substance P (SP) has been found to induce the release of 
vasoactive mediators from mast cells, macrophages, and T cells, 
contributing to chloride secretion, enhanced intestinal perme-
ability, and vascular leakiness.99,100 SP increases the expression of 
CRF1 receptor in mast cells, and in turn, CRF induces the ex-
pression of the specific receptor neurokinin (NK)-1.101 More re-
cently, psychological stress, through SP release, mediated 
stress-induced CRF expression in mice eosinophils and eosino-
phil-derived CRF was responsible for mast cell activation and ep-
ithelial barrier dysfunction. In this work, a cell line of eosinophils 
was treated with a number of stress mediators, but only SP in-
duced CRF release via NK-1 and NK-2. Moreover, priming of 
eosinophils with SP resulted in mast cell activation through eosi-
nophil-derived CRF that in turn induced intestinal barrier 
dysfunction.102 Wallon et al83 examined non-inflamed colonic 
mucosal biopses from patients with ulcerative colitis and found 
that eosinophils displayed immunoreactivity to CRF. In addition, 
in co-culture studies, carbachol activation of eosinophils induced 
CRF release and subsequent activation of mast cells, which in-
creased permeability of epithelial cells to macromolecules.83 
Similar to mast cells, eosinophils have also been shown to localize 
close to airway nerve terminals in patients with asthma as well as 
in animal models of bronchial hyperreactivity.103,104 This prox-
imity to nerve terminals is described in certain digestive dis-
orders,105,106 providing the anatomical substrate to understand the 
relevance of the mast cell-eosinophil-stress/CRF axis in the regu-
lation of epithelial permeability and the initiation of immune and 
inflammatory diseases.
Stress-induced increase in gut paracellular permeability has 
also been shown to depend on CRF1 receptor-mediated mast cell 
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release of nerve growth factor (NGF). Maternal deprivation has 
been shown to enhance colon permeability in association with ele-
vated NGF expression.76 A subsequent study from the same 
group showed that CRF, acting through its receptor CRF1 re-
ceptor, stimulated NGF release from mast cells, which in turn in-
creased gut paracellular permeability.80 Dendritic cells are rele-
vant for the regulation of intestinal immune function and perme-
ability through CRF production, a process augmented by com-
mensal bacteria.107 Similarly, CRF1 and CRF2 receptor agonists 
exert a biphasic effect on macrophages. During the early stages of 
the inflammatory response, they suppress TNF- release via in-
duction of cyclooxygenase-2/prostaglandin E2 while later on they 
induce TNF- transcription.108 Unfortunately, the role of 
CRF-mediated activation of macrophages and dendritic cells in 
stress-related intestinal barrier dysfunction is largely ignored.
Vanuytsel et al38 have recently shown that, both psychological 
stress (public speech) and a single intravenous bolus of CRF (100 
g) increased small intestinal permeability in healthy humans, 
measured by the lactulose/mannitol ratio. Two weeks pretreat-
ment with 800 mg/day of the mast cell stabilizer, disodium cromo-
glycate, blocked the effect of both stress and CRF, invoking the 
participation of the CRF-mast cell axis in this response.38 We have 
also observed in healthy volunteers that cold pain stress enhanced 
both the blood-to-lumen albumin65 ratio and the blood-to-lumen 
mannitol and xylose permeability.109 This response was mainly ob-
served in females with higher background stress levels, suggesting 
an impaired epithelial response to incoming stressful stimuli in 
this group. In addition, acute cold stress was shown to induce a 
significant release of -defensin in the jejunum in this study, sup-
porting the possibility that stress might affect this protective path-
way in the gut, as have been shown in the skin.110 Furthermore, we 
have also found that cold stress evoked a differential gender-de-
termined increase in human intestinal macromolecular 
permeability.111 This enhanced permeability could lead to ex-
cessive uptake of luminal antigens and bacterial products that may 
initiate an inflammatory response in the mucosa.112 Other studies 
showing the effect of stress and CRF on intestinal and extra-
intestinal permeability are shown in Tables 1 and 2, respectively.
Clinical Consequences of Stress/ 
Corticotropin-releasing Factor-mediated 
Dysregulation of Gastrointestinal 
Permeability
The growing acknowledgment of the scientific community to 
the role of intestinal permeability in keeping health and well-be-
ing and its relation to the origin of digestive and extradigestive 
disorders is becoming more and more universal for clinicians. 
Increased permeability and breakdown of intestinal barrier have 
been implicated in the origin of gastrointestinal and liver dis-
orders, including celiac disease,113 inflammatory bowel dis-
ease,114-118 food allergy,119 acute pancreatitis,120 irritable bowel 
syndrome (IBS),121,122 functional dyspepsia,123 infectious diar-
rheal syndromes,124 primary biliary cirrhosis, and primary scleros-
ing cholangitis,125 liver cirrhosis,126 alcoholic liver disease,127 liver 
encephalopathy,128 and gastroesophageal reflux disease,129-131 
among others. However, whether enhanced gut permeability is 
an early manifestation of disease, a central step in disease patho-
genesis, or a simple epiphenomenon, and its relationship with life 
stress in the clinical setting, remains to be elucidated. A few ex-
amples can illustrate this controversy.
Interestingly, life events may favor the clinical appearance of 
celiac disease,132 and cellular stress, through MHC class I chain 
related genes A and B and endoplasmic reticulum stress path-
ways, is linked to the disregulation of mucosal homeostasis.133,134 
Early in the 80s, celiac patients were shown to display increased 
intestinal permeability that normalized after several months on a 
gluten-free diet.113 More precise in vitro investigations revealed 
that although strict gluten withdrawal restored intestinal histol-
ogy, a subjacent defect in mucosal permeability, measured by cel-
lobiose/mannitol ratio, was transiently induced by short exposure 
to gluten, suggesting that increased intestinal permeability in cel-
iac disease could be a primary defect.135 Recently, this defect in 
intestinal permeability has been related to altered expression of 
TJ genes related to permeability, polarity, and cell proliferation in 
active celiac disease,136 partly through the activation of the zon-
ulin pathway in a MyD88-dependent fashion.137,138 Again, the 
majority of genes returned to normal after 2 years of gluten evic-
tion with the exception of PPP2R3A, possibly indicating a con-
stitutive defect in these patients.136 Moreover, unlike celiac dis-
ease, gluten sensitivity is not associated with increased intestinal 
permeability.139
Increased intestinal permeability has also been described in 
patients with inflammatory bowel disease. Enhanced intestinal 
permeability in this population is considered an initial event be-
cause it is increased in first-degree relatives of Crohn’s disease 
patients.140,141 Several observations link clinical relapses to the in-
crease in intestinal permeability142,143 and to life stress,144,145 partly 
through mast cell activation146 and the release of CRF from eosi-
nophils83 and neighboring nerves.68 Moreover, inflammatory 
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Table 1. Studies Showing the Effect of Stress/Corticotropin-releasing Factor on Intestinal Permeability
Author Permeability assessment methods Stress model Results
Santos et al,37 
1999
Ussing chambers measuring 
conductance (G), short-current 
circuit (Isc) and horseradish 
peroxidase (HRP) flux in rat colon
Restraint stress and 
corticotrophin-relea
sing factor (CRF) 
administration
Restraint stress increased colonic ion secretion and permeability 
to ions, bacterial peptide  peptide N-formyl-methionyl-leucyl- 
phenylalanine (fMLP), and HRP. These changes were 
prevented by alpha-helical CRF9-41 and mimicked by CRF 
administration. Pre-treatment with hexamethonium, bretylium 




Ussing chambers measuring G, 






Cold-restraint stress, and WAS significantly elevated G and 
HRP flux. CRF mimicked the stress responses. Alpha-helical 
CRF9-41 inhibited the stress-induced abnormalities.
Guilarte et al,164 
2004
Albumin release to the intestinal 
lumen in healthy volunteers and 
irritable bowel syndrome
CRF administration CRF induced a significant increase in albumin release to the 
intestinal lumen.
Gareau et al,180 
2006
Ussing chambers measuring G, and   
 Isc in rat colon
Neonatal maternal 
separation.
Neonatal maternal separation stress increased plasmatic 
corticosterone, enhanced ion secretion, macromolecular 
permeability, bacteria adhering, and penetration into the colonic 
epithelium. Alpha-helical CRF9-41 reversed stress-induced 
effects.
Yang et al,82 
2006
Ussing chambers measuring G, Isc 
and HRP flux in rat jejunum
WAS and oral HRP 
sensitization
Antigen challenge induced a rapid ion secretory response and an 
increase in G only in rats submitted to WAS. These effects were 
reversed by alpha-helical CRF9-41.
Gareau et al,78 
2007
Ussing chambers measuring HRP 
flux in rat colon
Neonatal maternal 
separation
Neonatal maternal separation stress increased HRP flux. The 
enhanced flux was inhibited by atropine and hexamethonium. 
Alpha-helical CRF9-41 and antisauvagine-30 inhibited 
stress-induced increase in HRP flux.
Santos et al,59 
2008
Ussing chambers measuring Isc and 
HRP flux in rat colon
CRF and sauvagine 
exposure
Sauvagine and CRF induced a dose-dependent increase in Isc 
and HRP flux and an enhancement in protease II pre-treatment 
with astressin, and doxantrozole inhibited this response. 




Ussing chambers measuring G, Isc 
and HRP flux in rat colon
CRF administration Chronic CRF administration increased Isc, G, and HRP flux, 
but not in mast-cell deficient rats. CRF administration induced 
mast cell hyperplasia and abnormal bacterial attachment into the 
mucosa that was absent in mast-cell deficient rats. 
Alonso et al,65 
2008
Albumin release to the intestinal 
lumen in healthy volunteers
Cold Pain Stress Cold pain stress induced a significant increase in albumin release 
to the intestinal lumen.
Wallon et al,68 
2008
Ussing chambers measuring Isc, 
HRP flux, 51Cr-EDTA, and  
transepithelial resistance (TER) in 
human colon
CRF administration CRF increased permeability to HRP. The increased 




Evans blue extravasation in rat colon Cortagine 
administration
Cortagine induced a significantly increased intestinal 
permeability. Astressin-B abolished the cortagine-induced 
increase in intestinal permeability.
Zheng et al,102  
2009
Ussing chambers measuring Isc, 
HRP flux, and TER in mouse 
jejunum
Restraint stress and 
substance P (SP) 
exposure
SP stimulation induced a significant increase in  Isc and HRP 
flux in stressed mice. Those changes were lower in mast 
cell-deficient mice.  Alpha-helical CRF9-41, inhibited 
SP-induced intestinal barrier dysfunction. 
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Table 1. Continued
Author Permeability assessment methods Stress model Results
Smith et al,58 
2010
Ussing chambers measuring Isc, 3H 
mannitol flux, 14C inulin flux, and 
TER in pig jejunum and colon
Early weaning Early weaning reduced jejunal TER and enhanced Isc and 
mucosal-to-serosal flux of 3H mannitol and 14C inulin in 
association with increased lamina propria mast cell density. 
Sodium cromoglycolate ameliorated barrier dysfunction and 
hypersecretion in early-weaned pigs. C48/80 and CRF exposure 
increased Isc  and induced intestinal barrier dysfunction that 
were inhibited with mast cell protease inhibitors. 
Keita et al,181  
2010
Ussing chambers measuring G, Isc, 
HRP flux, 51Cr-EDTA, and 
Escherichia coli K-12 flux in rat 
follicle-associated epithelium (FAE) 
and villus epithelium (VE) from rat 
ileum
WAS WAS increased G, Isc, HRP and E. Coli uptake in FAE and VE. 
SP increased bacterial and 51Cr-EDTA intestinal permeability. 
These results were mimicked by CRF and carbachol and 
reduced by doxantrazole, CRF receptor antagonist and 
atropine. 
Wallon et al,83 
2011
Ussing chambers measuring Isc, 
HRP flux, 51Cr-EDTA, fluorescein 
isothiocyanate (FITC)-Dextran 
4000, and TER in non inflamed 
human colon biopsies from ulcerative 
colitis patients
None HRP flux, TER, and Isc were increased in mucosa from patients 
with UC. Alpha-helical CRF9-41, atropine and lodoxamide 
reversed the increase in intestinal permeability.
Alonso et al,111 
2012
Albumin release to the intestinal 
lumen in healthy volunteers
Cold Pain Stress Cold pain stress induced a significant increase in albumin release 
to the intestinal lumen.
Ait-Belgnaoui 
et al,182 2012
Ussing chambers measuring 
FITC-Dextran flux in rat colon
Partial restraint stress Stress increased plasma ACTH and corticosterone, and 
hypothalamic CRF and enhanced colonic paracellular 




Ussing chambers measuring 
FITC-Dextran flux in porcine ileum
CRF exposure CRF increased paracellular FITC-Dextran flux. Pre-treatment 
with astressin-B, sodium cromolyn, anti-TNF-α antibodies, 
protease inhibitors, and tetrodotoxin inhibited CRF-mediated 
intestinal barrier dysfunction.
Vicario et al,53 
2012
Ussing chambers measuring G and Isc 
in rat colon
Crowding stress and 
CRF administration
Crowding stress significantly increased G and Isc and CRFR1 in 
the rat colon. CRF administration mimicked stress-induced 
epithelial dysfunction. 
Hill LT et al,183 
2013
Lactulose-mannitol urinary excretion 
test in shocked patients undergoing 
small bowel resection during 
emergency laparotomy and patients 
undergoing elective hepatobiliary 
surgery
Shock and abdominal 
surgery
Shock was associated with increased intestinal permeability. 
Plasma CRF was significantly increased in the shocked patients.
Yu et al,81 2013 HRP flux and TER in HT-29, T84, 
MDCK, and Caco2 monolayers
Ussing chambers measuring G, Isc, 
and HRP flux in mouse colon
CRF exposure and 
WAS
WAS increased G and Isc and HRP flux, and this increase was 
higher after LPS stimulation. This response was abolished by 
pre-treatment with anti-claudin 2 (Cldn2) antibodies. Stress 
also increased the expression of Cldn2 and toll-like receptor-4 
(TLR4) in mouse epithelium. Exposure to CRF induced Cldn2 
and TLR4 expression in intestinal epithelial cells. 
Vanuytsel 
et al,38 2014
Lactulose-mannitol urinary excretion 
test in healthy volunteers
Indomethacin 
administration, 




Public speech and CRF administration increased intestinal 
permeability and salivary cortisol. Increased permeability after 
public speech was only present in subjects with a significant 
elevation of cortisol. Pre-treatment with disodium cromoglycate 
inhibited stress and CRF-induced increased intestinal 
permeability.
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Table 2. Studies Showing the Effect of Stress/Corticotropin-releasing Factor on Extraintestinal Permeability
Author Permeability assessment methods Stress model Results
Wei et al,184 
1986
Evans blue extravasation in rat paw Antidromic stimulation of 
the saphenous nerve in 
innervated rat paw
Corticotropin-releasing factor (CRF) inhibited neurogenic 
plasma extravasation in the innervated rat paw. This effect 
was independent of the hypothalamus or the adrenal gland.
Wei and 
Kiang,185 1987
Evans-blue extravasation in rat 
trachea
Antidromic stimulation of 
the right vagus or exposure 
to dilute formalin vapors
CRF inhibited tracheal plasma protein extravasation.
Kiang et al,186 
1987
Evans-blue extravasation in rat paw Immersion of rat's paw in 
48oC or 58oC water
CRF inhibited thermal injury-induced pasma extravasation 
and edema.
Wei et al,187 
1988
Fluid displacement method in rat 
paw
Immersion of anesthetized 
rat paw in 58oC water
CRF inhibited the progressive development of swelling, and 
reduced edema, epidermal necrosis and the disruption of 
tissue architecture produced by thermal injury. CRF effects 
were reverted by alpha-helical CRF9-41.
Tian and 
Wei,188 1989
Changes in skin weight and Evans 
blue extravasation in rat paw
Anesthetized rat paw 
immersion in 12 N 
hydrochloric, 18 N sulfuric, 
or 14 N hydrofluoric acids
CRF reduced the skin acid-induced skin injury.
Wei and 
Kiang,189 1989
Evans blue extravasation in rat paw Anesthetized rat paw 
immersion in 48oC or 58oC 
and antidromic stimulation 
of the saphenous nerve
Sauvagine and CRF inhibited plasma extravasation induced 
by thermal and neurogenic injury. 
Serda and 
Wei,190 1991
Evans blue and Monastral 
extravasation in rat paw
Anesthetized rat paw 
immersion in 22% NaCl 
solution maintained at 
−20 ± 0.5oC.
CRF inhibited the acute inflammatory response of rat paw 
skin to cold injury. The anti-inflammatory effects of CRF 
were blocked by alpha-helical CRF9-41.
Wei and 
Gao,191 1991
Monastral blue extravasation in rat 
paw
Mechanical injury to muscle 
produced by a midline 
surgical incision in the 
rectus abdominis or freeze 
injury to the cortex 
produced by applying a cold 
probe (−50oC) to the skull
CRF inhibited the leakage of small blood vessel due to 
muscle and brain injury.
Gao et al,192 
1991
Monastral blue extravasation in rat 
skin, muscle, trachea and 
esophagus
Substance P (SP) 
administration
SP induces plasma protein leakage in skin, muscle, trachea 
and esophagus. This effect was reverted by the treatment 
with CRF.
Kelley et al,193 
1994
Measurement of lung wet-to-dry 




Pulmonary vascular leak, and leukocyte infiltration were 
significantly depressed by CRF treatment.
Yoshihara 
et al,194 1995
Evans blue extravasation in Guinea 
pig trachea and main bronchi
Antigen challenge through 
inhalation of 5% ovalbumin 
in the presence of 
phosphoramidon
CRF reduced ovalbumin-induced plasma extravasation in 
guinea pig airways by inhibiting the release of tachykinins 
from primary sensory nerves.
Whitney 
et al,195 1997
Comparison of rat preischemic 
amputated limb weight with weight 
after ischemia and reperfusion
Hind limb replantation CRF inhibited the gain of weight by ischemia-reperfusion 




Evans blue vascular extravasation 
in the rat skin
CRF administration CRF induced mast cell degranulation and increased capillary 
permeability, and the antalarmin blocked this effect. 
Whitney 
et al,197 1998
Comparision of rat pedicled hind 
limb weight with ischemic 
pedicled hind limb weight
Pedicled hind limb CRF administration decreased limb weight gain.
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Table 2. Continued
Author Permeability assessment methods Stress model Results
Singh et al,198 
1999




Ucn induced rat skin mast cell degranulation and increased 
vascular permeability. Alpha-helical CRF9-41, antalarmin 
and astressin reverted this effect. 
Rapallino 
et al,199 2001
Ionic permeability of rabbit 
vestibular Deiters neurons 
membrane
Rotation platform CRF blocked basal chloride permeation across the Deiters' 




99Tc gluceptate extravasation in rat 
brain
Restraint stress Acute stress and CRF paraventricular nucleus injection 
increased blood-brain-barrier 99Tc gluceptate 




Evans blue vascular extravasation 
in rat brain
Closing of both internal 
carotid arteries
CRF decreased the endothelial damage in the acute phase of 
the ischemia.
Huang et al,202 
2002
99Tc gluceptate extravasation in 
mice skin and knee joints
Restraint stress Vascular permeability to 99Tc, as well as local CRF levels, 
were increased by stress, but not in mast-cell deficient mice.
Lytinas et al,203 
2003
99Tc gluceptate and Evans blue 
extravasation in rat skin
Restraint stress Acute stress increased skin CRF and vascular permeability. 




Evans blue extravasation in mice 
skin
CRF administration CRF increased vascular permeability. The neurotensin 
blocker (SR48692) inhibited CRF effects. CRF-induced 
increased vascular permeability was absent in mast cell 
deficient mice.
Wu et al,205 
2006
Evans blue extravasation in the rat 
lung
Ucn aerosol inhalation Ucn inhalation increased lung vascular permeability. 
Enhanced pulmonary vascular permeability induced by 
Ucn was markedly inhibited by pretreatment with 
cromolyn, and azelastine.
Cureton et al,206 
2009
Measurement o hydraulic and 




LPS and Ucn incremented hydraulic permeability. CRF2 
receptor blockade decreased the LPS-induced increase in 
hydraulic permeability.
Boucher et al,97 
2010
Evans blue extravasation in mice 
bladder
Restraint stress Acute stress increased bladder vascular permeability. CRF2 
receptor and astressin2-B inhibited this effect.
Song et al,207 
2013
Transepithelial resistance (TER) 
and permeability to horseradish 
peroxidase (HRP) in human 
endothelial cell monolayers 
(Hmvec)
CRF treatment Exposure to CRF induced TNF-alpha release by CD14 
effector cells, decreased TER and increased permeability to 
HRP in co-cultured Hmvec monolayers.
Wan et al,208 
2013
Crystal violet, FITC-Dextran and 




Pretreatment of HUVECs with urocortin increased 
LPS-induced endothelial permeability by regulating the 
cadherin-catenin complex via CRF2 receptor. 
bowel disease patients show associations with genes involved in 
the regulation of intestinal barrier and various alterations of the 
transmembrane and intracytoplasmic proteins.147,148 In addition, 
increased CRF1 receptor
66 and Ucn expression, but decreased 
CRF2 receptor
67 expression have been shown in the colonic mu-
cosa of active ulcerative colitis patients.149,150
Accumulating evidence also indicates that IBS is linked to 
abnormal intestinal permeability,151-153 CRF release and life 
stress154-157 in close association with low-grade mucosal inflam-
mation and immune activation.158 Several groups have provided 
preliminary evidence linking clinical manifestations of IBS to 
structural abnormalities of the apical junctional complex in both 
the small159,160 and large bowel mucosa.81,161-163 Furthermore, un-
published observations from our group indicate that a single in-
travenous bolus of CRF (100 g) increased intestinal perme-
ability, measured as the blood-to-lumen albumin ratio, in healthy 
subjects and in IBS patients through mast cell activation.164
In the same line, increased intestinal permeability and stress/ 
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CRF axis have also been involved in the pathophysiology of food 
allergy, as these patients display an enhancement of intestinal per-
meability even in the absence of food allergens165 and stress facili-
tates sensitization to luminal antigens.82 In fact, patients following 
immunosuppressive treatment have been shown to develop 
new-onset food allergies that may be related to the increase in in-
testinal permeability induced by treatment.166
Many other stress-related conditions such as severe burn,167,168 
hemorragic shock,169 chronic kidney disease,170 type 1 diabetes 
and the metabolic syndrome,171,172 neuropsychiatric disorders,173 
autism,174 autoimmune thyroiditis,175 IgA nephropathy,176 pa-
tients with primary immunodeficiencies,177 and sepsis178 have 
been associated with increased intestinal permeability. 
Conclusion
The ability of stress and peripheral CRF to affect intestinal 
epithelial function and, particularly, intestinal permeability, is 
well documented in human and several animal species. Interest-
ingly, apart from the direct effects on the enterocytes, the stress- 
induced increase of intestinal permeability is mediated via recruit-
ment and activation of mast cells, eosinophils, macrophages and 
other mononuclear cells, and implicates both CRFR1 and CRF2 
receptors.28
There is abundant literature supporting the link between life 
stress and the origin and clinical course of several human dis-
orders,179 however, the ultimate clinical relevance of stress-CRF- 
mediated dysregulation of gastrointestinal permeability, remains 
at present mostly intuitive, with few exceptions. More work in 
this area is needed to confirm the findings. In this sense, studies 
with CRF and related peptides and the development of new an-
tagonists for human use, will offer the opportunity to test this 
hypoyhesis.
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